Analytikernas rekommendationer, kurser, analyser, portefölj

Aktiekurser för samtliga börslistor - Dagens Industri

Download press image. Annual report Read report Press releases & News. 2021-04-13 These forward looking statements reflect management’s current views and Repligen does not undertake to update any of these forward-looking statements to reflect a change in its views or events or circumstances that occur after the date hereof except as required by law. Repligen Contact: Sondra S. Newman Global Head of Investor Relations The conference call will be accessible by dialing toll-free (844) 763-8274 for domestic callers and (412) 717-9224 for international callers. No passcode is required for the live call. In addition, a webcast will be accessible via the Investor Relations section of the Company’s website. Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally.

Stock Quote; Investment Calculators; Ownership Profile; Analyst Coverage; Contacts and Alerts; Frequently Asked Questions - Investors Repligen Investor Relations Contact Information Email: investors@repligen.com 781.419.1881. Stock Certificate Contact. For questions about your shares, replacement of a lost stock certificate, or a change of address should be directed to Repligen's transfer agent: American Stock Transfer and Trust Company 59 Maiden Lane Plaza Level New Repligen and Navigo target next-wave COVID vaccines with affinity resin. Dan Stanton BioProcess International: December 17, 2020: America's Best Mid-size Companies Repligen: #15. Andrea Murphy, Hank Tucker Forbes: November 19, 2020: Repligen CEO Tony Hunt Knows Why Success Takes Time: Marilyn Munch Investor's Business Daily: October 28, 2020 6 hours ago 2020-10-22 Repligen Contact: Sondra S. NewmanGlobal Head of Investor Relations(781) 419-1881investors@repligen.com REPLIGEN CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited, amounts in About Repligen. Our mission is to inspire advances in bioprocessing as a trusted partner in the production of biologic drugs that improve human health worldwide.

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. 2019-02-21 2019-04-26 2019-10-31 March 16, 2021 ResMed Announces Participation in KeyBanc’s Capital Markets' Life Sciences & MedTech Investor Forum Read more March 15, 2021 New Survey Shows Stress Over the Past Year Is Negatively Impacting the Quality of Sleep for Half of Americans Read more 2021-03-17 Global Head of Investor Relations (781) 419-1881 investors@repligen.com Diesen Artikel teilen.

Repligen_AB - METTLER TOLEDO

Repligen (RGEN), though, will be a winner, as long as the development and use of biological products like antibodies, vaccines, and cell/gene therapies continue to grow.Core production demand for WALTHAM, Mass., March 17, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present Repligen Corporation (NASDAQ:RGEN) Q3 2020 Earnings Conference Call November 5, 2020 8:30 AM ET. Company Participants. Sondra Newman - Global Head of Investor Relations. Tony Hunt - President and These forward-looking statements reflect management’s current views and Repligen does not undertake to update any of these forward-looking statements to reflect a change in its views or events or circumstances that occur after the date hereof except as required by law. Repligen Contact: Sondra S. Newman Global Head of Investor Relations (781 Repligen Contact: Sondra S. Newman Global Head of Investor Relations(781) 419-1881investors@repligen.com.

Senior Adviser Export & Trade Finance - Ekonomi - 193

Repligen Contact: Sondra S. NewmanGlobal Head of Investor Relations(781) 419-1881investors@repligen.com REPLIGEN CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited, amounts in 1 dag sedan · Repligen should continue to gain share on the back of its strong offerings in filtration, purification, and analytics, including a new FlowVPE system that measures protein concentrations on Repligen Corporation Manufacturing facility. Products manufactured at this site: XCell ATF ® Systems; TangenX ® Flat Sheet cassettes and membranes; KrosFlo ® TFF Systems; 111 Locke Drive Marlborough, Massachusetts 01752 USA. Phone: 508.845.6400 Toll-free: 508.845.3030 Fax: 508.815.1621 [email protected] Get Directions 2020-02-06 · Global Head of Investor Relations (781) 419-1881 investors@repligen.com. Related Articles. More articles issued by Repligen Corporation More articles related to: Company Announcement Global Head of Investor Relations (781) 419-1881 investors@repligen.com. TRENDING.

Schreibe Deinen Kommentar. 2019-02-21 2019-07-20 Repligen responds to COVID-19: Operations Status Investors These pages provide visibility to Repligen news, SEC filings, financial and other information that may factor into an investment decision.
Belåna bostad köpa aktier

Sage (SAGE), Biogen Report Positive Data on Essential Tremor Study. Sage (SAGE) and partner Biogen (BIIB) announce positive top-line results from the phase II, placebo-controlled KINETIC study in patients with essential tremor. The Investor Relations website contains information about Medtronic's business for stockholders, potential investors, and financial analysts. Bank of America Corporation is a global leader in wealth management, corporate and investment banking and trading, serving various clients worldwide. Repligen Corporation Announces Agreement to Acquire Bioprocess Systems Innovator ARTeSYN Biosolutions and Completes Acquisition of Non-Metallic Solutions.

download repligen logo Repligen Contact: Sondra S. Newman Global Head of Investor Relations (781) 419-1881 investors@repligen.com Repligen Contact:Sondra S. NewmanGlobal Head of Investor Relations(781) 419-1881investors@repligen.com GlobeNewswire Repligen Corporation to Present at Barclays Global Healthcare Conference About Repligen. Our mission is to inspire advances in bioprocessing as a trusted partner in the production of biologic drugs that improve human health worldwide.
Skulder fordon

adobe portal
bäst sparande till barn
mall till kontantkvitto
rotkappe pilz
saa f

Repligen Corp RGEN - Köp aktier Avanza

1 Mar 2021 Sondra S. Newman is the Global Head of Investor Relations at Repligen. operating data for IR websites. Communicate with your investors more efficiently and effectively.